Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 221   

Articles published

PFE 34.00 -0.29 (-0.85%)
price chart
Pfizer and the National Newspaper Publishers Association Collaborate to Raise ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) and the National Newspaper Publishers Association (NNPA), a trade association of more than 200 African-American–owned community newspapers from around the United States, are collaborating to ...
EOD Risers: Microsoft Corporation, Pfizer Inc., Travelers Companies Inc
Shares of Pfizer Inc. company symbol: (NYSE:PFE) a research-based global biopharmaceutical company, gained 0.64% or 0.22 points throughout yesterday's trading day.
Pfizer Inc. (PFE) Closes 0.85% Down on the Day for March 24
Shares of Pfizer Inc. (PFE) ended the trading day Friday at $34.00, representing a move of -0.85%, or $0.29 per share, on volume of 26.59 million shares.
Frontier Wealth Management LLC Boosts Stake in Pfizer Inc. (PFE)  BNB Daily (blog)
SSI Investment Management Inc. Has $789000 Position in Pfizer Inc. (PFE)  The Cerbat Gem
Pfizer Is Positioned For Dividend Growth With Limited Downside
The drug pipeline, both in terms of new drugs and expiring patents, is the lifeblood of a pharmaceutical company. Pfizer's patent cliff does not pose a major threat over the next few years. Below are the three largest concerns (data from Pfizer's ...
Pfizer, Merck KGaA's $13000-a-Month Cancer Drug Wins Approval
Pfizer Inc. and Merck KGaA's immunotherapy, priced at $13,000 a month, won the backing of U.S. regulators for patients with a rare and deadly form of skin cancer, giving the companies a foothold in one of the most promising new fields of medicine.
Pfizer Subpoenaed in DOJ Investigation of Drugmaker Charity Connections
Last year, Gilead Sciences Inc., Biogen Inc. and Jazz Pharmaceuticals Plc said they had received subpoenas for documents related to the nonprofits.
Pfizer subpoenaed in US over patient assistance plans  Reuters
EOD Risers: Merck & Co., Inc., Microsoft Corporation, Nike Inc, Pfizer Inc ...
The trading price for Merck & Co., Inc. EPIC code: (NYSE:MRK) a global healthcare company, increased 0.33% or 0.21 points during yesterday's session.
Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval
Pfizer, Inc. PFE and German partner Merck KGaA's investigational cancer treatment, avelumab, was approved by the FDA for the treatment of metastatic Merkel cell carcinoma (MCC), a rare and aggressive form of skin cancer.
FDA approves Pfizer, German Merck immunotherapy for skin cancer  Business Insider
Pfizer Inc. (NYSE:PFE) Planning $100M Plant Expansion In The Triangle
Reliable sources have also indicated that Pfizer is exploring options to locate the project in Massachusetts. Pfizer is currently working on the expansion of its Andover plant at a total cost of $200. The expansion is aimed at expanding the company's ...
Is Pfizer (PFE) a Great Stock for Value Investors?
Though Pfizer might be a good choice for value investors, there are plenty of other factors to consider before investing in this name.